Researcher
Tine Wyseure
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Pharmaceutics, Drug discovery and development
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Apr 2013 → 31 Dec 2014
Projects
1 - 1 of 1
- In vivo evaluation of the dual inhibition of TAFI and PAI-1: towards effective and safe thrombolysisFrom1 Oct 2009 → 22 Sep 2014Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 11
- Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice(2016)
Authors: Frederik Denorme, Tine Wyseure, Ann Gils, Hans Deckmyn, Karen Vanhoorelbeke, Paul Declerck, Simon De Meyer
Pages: 2419 - 2422 - Development of an LC/MS assay for the bacterial transglycosylation reaction through measurement of Lipid II(2015)
Authors: Bart Blanchaert, Tine Wyseure, Eefjan Breukink, Erwin Adams, Paul Declerck, Ann Van Schepdael
Pages: 2841 - 2849 - Development of an LC/MS assay for the bacterial transglycosylation reaction through measurement of Lipid II(2015)
Authors: Bart Blanchaert, Tine Wyseure, Erwin Adams, Paul Declerck, Ann Van Schepdael
Pages: 2841 - 2849 - Inhibition of TAFI and PAI-1 is protective in a mouse model of cerebral ischemia/reperfusion injury(2015)
Authors: Frederik Denorme, Tine Wyseure, M Peeters, Ann Gils, Paul Declerck, Simon De Meyer
Pages: 695 - 696 - Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke(2015)
Authors: Tine Wyseure, Frederik Denorme, Ann Gils, Simon De Meyer, Paul Declerck
Pages: 1325 - 32 - Novel or expanding current targets in fibrinolysis(2014)
Authors: Tine Wyseure, Paul Declerck
Pages: 1476 - 1482 - Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1(2013)
Authors: Tine Wyseure, Ann Gils, Paul Declerck
Pages: 2069 - 2071 - Bioanalytical study of the bacterial transglycosylation reaction(2013)
Authors: Bart Blanchaert, Eefjan Breukink, Tine Wyseure, Paul Declerck, Erwin Adams, Ann Van Schepdael, F Foret, J Krenkova, I Drobnikova, K Kleparnik
Pages: 35 - 36Number of pages: 2 - Antibody-engineered bispecific inhibitor against TAFI and PAI-1 with improved expression and efficacy(2013)
Authors: Tine Wyseure, Jan Develter, Efthymia Tziarou, Ann Gils, Paul Declerck, Pieter Reitsma, Frits Rosendaal
Pages: 659 - 659 - Bispecific inhibition of TAFI and PAI-1 as a fibrinolytic enhancer(2012)
Authors: Tine Wyseure, Ellen Vercauteren, Ann Gils, Paul Declerck
Pages: E19 - E19
Patents
1 - 3 of 3
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)